Cegedim SA (EPA:ALCGM)
France · Delayed Price · Currency is EUR 11.40
-0.10 (-0.87%)
Jun 23, 2026, 5:37 PM CET
Cegedim Market Cap
Cegedim has a market cap or net worth of €156.53 million as of June 23, 2026. Its market cap has increased by 7.68% in one year.
Market Cap
156.53M
Enterprise Value
405.83M
Revenue
649.17M
Ranking
n/a
PE Ratio
16.68
Stock Price
€11.40
Market Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 156.53M, an increase of 37.49%. That is a compound annual growth rate of 1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 156.53M | -16.10% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 88.18B |
| EssilorLuxottica Société anonyme | 77.30B |
| Sartorius Stedim Biotech | 15.88B |
| Ipsen | 13.35B |
| Transgene | 202.67M |
| Median Technologies | 185.10M |
| Cellectis | 177.87M |
| Bastide Le Confort Médical | 171.22M |